LOS ANGELES Thousands of individuals currently taking angiotension converting enzyme (ACE) inhibitors, a type of medication commonly used to lower blood pressure, may be doing more than treating their hypertension. According to research presented today at Digestive Disease Week 2006 (DDW), ACE inhibitors not only effectively lower blood pressure, but they are also associated with a significant decrease in risk of developing three types of cancers: esophageal, pancreatic and colon. DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Using a study population of nearly 500,000 U.S. veterans, researchers from the Overton Brooks VA Medical Center in Shreveport, LA, completed three case-controlled studies examining the correlation between ACE inhibitor use and esophageal, pancreatic and colon cancer incidence. The team analyzed statistics from the Veterans' Integrated Service Network (VISN 16) database, a resource tool containing information about every veteran that has received care from the South Central VA Health Care Network from October 1998 to June 2004. Among the 483,733 patients in the study, 659 had esophageal cancer, 475 had pancreatic cancer, and 6,697 had colon and rectal cancer; approximately 38 percent were taking ACE inhibitors.
While ACE inhibitors were associated with a reduction in risk for all three cancer types, it was most effective in lowering the risk of developing esophageal cancer, with a 55 percent risk reduction as compared to the controls. Results from the second study showed that ACE inhibitor use offered a 48 percent reduced risk of pancreatic cancer. And in the third study, investigators found that ACE inhibitor use was associated with a 47 percent reduced risk of colon cancer.
The studies were controlled for age, race, gender, body mass index, smoking, alcohol use, reflux, non-steroidal antPage: 1 2 Related medicine news :1
Contact: Aimee Frank
American Gastroenterological Association
. Blood inflammation plays role in Alzheimers disease2
. Blood-thinning drugs need closer monitoring3
. Blood transfusions from precancerous blood donors do not increase risk of cancer4
. Blood marker helps predict prognosis among those with abdominal infection5
. Blood transfusions raise heart patients infection and death risk -- especially women6
. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find7
. Blood cells linked to heart attacks, other inflammatory diseases8
. Blood transfusion-transmitted infections: A global perspective9
. Blood clots can be treated by injections at home10
. Blood pressure variability increases risk for stroke death11
. Canadian Blood Services scientist invents potential alternative for high-demand blood product